Cargando...
Strategies for the Treatment of Parkinson’s Disease: Beyond Dopamine
Parkinson’s disease (PD) is the second-leading cause of dementia and is characterized by a progressive loss of dopaminergic neurons in the substantia nigra alongside the presence of intraneuronal α-synuclein-positive inclusions. Therapies to date have been directed to the restoration of the dopamine...
Gardado en:
| Publicado en: | Front Aging Neurosci |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7006457/ https://ncbi.nlm.nih.gov/pubmed/32076403 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnagi.2020.00004 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|